Related Experiment Videos
Acute preload effects of furosemide
P A Kraus1, J Lipman, P J Becker
1Department of Anesthesia, Haragwanath Hospital, Johannesburg, South Africa.
Chest
|July 1, 1990
Summary
Intravenous furosemide initially increased pulmonary capillary wedge pressure (PCWP) in some patients but decreased it when combined with preload and afterload reduction. This effect was independent of patient condition or furosemide dose.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Pulmonary capillary wedge pressure (PCWP) is a key indicator of cardiac preload.
- Furosemide is a diuretic commonly used in managing fluid overload.
- Understanding the acute hemodynamic effects of furosemide is crucial for patient management.
Purpose of the Study:
- To investigate the acute preload effects of intravenous furosemide bolus.
- To determine how concurrent vasoactive medications influence furosemide's hemodynamic impact.
- To explore the relationship between furosemide, PCWP, and vasoconstrictor release.
Main Methods:
- Studied 33 patients receiving intravenous furosemide bolus.
- Monitored pulmonary capillary wedge pressure (PCWP) at various time points.
- Analyzed PCWP trends in patients with and without vasoactive drug support (preload and afterload reduction).
Main Results:
- Furosemide alone or with preload reducers caused an initial rise in PCWP, followed by a fall below baseline.
- Patients receiving combined preload and afterload reduction experienced an immediate and sustained drop in PCWP.
- These hemodynamic trends were consistent regardless of underlying pathology or furosemide dosage.
Conclusions:
- Furosemide may trigger early release of endogenous vasoconstrictors.
- Combined preload and afterload reduction can mitigate potential adverse hemodynamic effects of furosemide.
- Concurrent hemodynamic management is essential when administering furosemide.